"Global CDMO Business to Gain Momentum"

Boryung announced on November 10 that its solid dosage manufacturing facility at the Yesan Campus, its production complex in Yesan, South Chungcheong Province, has obtained European Union Good Manufacturing Practice (EU-GMP) certification.


EU-GMP sets the manufacturing and quality control standards required to supply medicines to the European Union market. Along with the U.S. Food and Drug Administration's (FDA) cGMP, it is considered one of the world's highest-level standards. Boryung first obtained EU-GMP certification for its anticancer injection manufacturing facility in 2023, and has now secured certification for its solid dosage manufacturing facility as well.


Boryung's Yesan Campus, a production complex located in Yesan, South Chungcheong Province. Boryung

Boryung's Yesan Campus, a production complex located in Yesan, South Chungcheong Province. Boryung

View original image

The company expects that passing a GMP inspection by Germany's regulatory authority, which operates a particularly rigorous and systematic oversight system even within Europe, will further accelerate its contract development and manufacturing organization (CDMO) and export businesses in global markets, including advanced regulatory markets such as Europe.


Building on this certification, Boryung plans to expand overseas supplies of key solid dosage medicines, including Zyprexa and Kanarb, while actively pursuing partnerships with global pharmaceutical companies and additional CDMO opportunities.


Completed in 2019, the Yesan Campus can produce approximately 870 million solid dosage forms annually. Production began in early 2020 with Stogar tablets, an anti-ulcer drug whose active ingredient is lafutidine. The campus currently produces the Kanarb product line, a hypertension treatment whose active ingredient is fimasartan, and Zyprexa, an original schizophrenia treatment whose active ingredient is olanzapine.



Park Gyeongsuk, head of Boryung's Production and Quality Division, said, "We will continue to enhance our manufacturing and quality capabilities so that the Yesan Campus can serve as a strategic hub for expanding our global business."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing